Trial · NCT03138733
Results by group44
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 44
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients With or Without Overall Success at the Post-treatment Evaluation (PTE) Visit | Ceftobiprole | Number of responders | 132 | Participants | |
| Number of Patients With or Without Overall Success at the Post-treatment Evaluation (PTE) Visit | Daptomycin | Number of responders | 136 | Participants | |
| Number of Patients With or Without Overall Success at the Post-treatment Evaluation (PTE) Visit | Ceftobiprole | Number of non-responders | 57 | Participants | |
| Number of Patients With or Without Overall Success at the Post-treatment Evaluation (PTE) Visit | Daptomycin | Number of non-responders | 62 | Participants | |
| Number of Patients With or Without Overall Success at the PTE Visit in the CE Population | Ceftobiprole | Number of responders | 127 | Participants | |
| Number of Patients With or Without Overall Success at the PTE Visit in the CE Population | Daptomycin | Number of responders | 130 | Participants | |
| Number of Patients With or Without Overall Success at the PTE Visit in the CE Population | Ceftobiprole | Number of non-responders | 36 | Participants | |
| Number of Patients With or Without Overall Success at the PTE Visit in the CE Population | Daptomycin | Number of non-responders | 37 | Participants | |
| Number of Patients With Microbiological Eradication at the PTE Visit | Ceftobiprole | 155 | Participants | ||
| Number of Patients With Microbiological Eradication at the PTE Visit | Daptomycin | 153 | Participants | ||
| All-cause Mortality at the PTE Visit | Ceftobiprole | Patients died | 17 | Participants | |
| All-cause Mortality at the PTE Visit | Daptomycin | Patients died | 18 | Participants | |
| All-cause Mortality at the PTE Visit | Ceftobiprole | Patients alive | 172 | Participants | |
| All-cause Mortality at the PTE Visit | Daptomycin | Patients alive | 180 | Participants | |
| Number of Patients With or Without New Metastatic Foci or Other Complications of SAB Developed After Day 7 | Ceftobiprole | Patients with development of new metastatic foci or other complications of SAB after Day 7 | 11 | Participants | |
| Number of Patients With or Without New Metastatic Foci or Other Complications of SAB Developed After Day 7 | Daptomycin | Patients with development of new metastatic foci or other complications of SAB after Day 7 | 11 | Participants | |
| Number of Patients With or Without New Metastatic Foci or Other Complications of SAB Developed After Day 7 | Ceftobiprole | Patients without development of new metastatic foci or other complications of SAB after Day 7 | 178 | Participants | |
| Number of Patients With or Without New Metastatic Foci or Other Complications of SAB Developed After Day 7 | Daptomycin | Patients without development of new metastatic foci or other complications of SAB after Day 7 | 187 | Participants | |
| Time to Staphylococcus Aureus Bloodstream Clearance | Ceftobiprole | 4 | 95% Confidence Interval 3 to 5 | Days | |
| Time to Staphylococcus Aureus Bloodstream Clearance | Daptomycin | 4 | 95% Confidence Interval 3 to 5 | Days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03138733/results